Target intelligence / Profile preview

Paracrine signaling modulation

Molecular classification
Other (not a molecule, receptor, or protein family)
01

Overview

Paracrine signaling is **not a specific molecule or receptor**, but rather a form of cell-to-cell communication in which one cell produces signals—called paracrine factors—that induce changes in nearby cells by diffusing over short distances. This process is distinct from endocrine signaling, which involves hormones traveling long distances via the bloodstream, and autocrine signaling, where cells respond to their own secreted signals. Paracrine factors include growth factors, cytokines, nitric oxide, neurotransmitters at synapses, and other locally acting molecules. These signals are typically rapidly degraded or taken up to ensure localized action. Paracrine modulation refers to the regulation or alteration of these local signaling processes. While many therapeutic agents may target specific molecules involved in paracrine pathways—such as growth factor receptors or enzymes producing paracrine mediators—the term "paracrine signaling modulation" itself does not refer to a discrete druggable target but rather an entire class of biological processes[1][3][4][5]. Therefore it cannot be classified as a canonical molecular target for drug development. > "Paracrine signaling is a form of cell signaling...in which a cell produces a signal to induce changes in nearby cells..."[1] > "Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly..."[2] In summary, **"paracrine signaling modulation"** describes an important biological process but does not correspond to any single molecular entity that could serve as the canonical name for structured data on therapeutic targets.

Other names
Paracrine signalingParacrine modulationParacrine communication
02

Biological functions

Signal transductionCell communicationRegulation of local cellular responsesTissue repair and wound healingVasodilationBlood clotting
03

Disease associations

Cancer (via dysregulation of paracrine pathways)Inflammation (local immune responses)Cardiovascular disease (e.g., vasodilation/vasoconstriction effects)Other (general tissue homeostasis and pathology)

Beyond the preview

Go deeper on Paracrine signaling modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine signaling modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call